Akira Homma

Summary

Affiliation: Rio de Janeiro
Country: Brazil

Publications

  1. ncbi request reprint Vaccine research, development, and innovation in Brazil: a translational science perspective
    Akira Homma
    Bio Manguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
    Vaccine 31:B54-60. 2013
  2. doi request reprint The Brazilian vaccine manufacturers' perspective and its current status
    Akira Homma
    Bio Manguinhos Fiocruz, Pavilhão Rocha Lima, Manguinhos, Rio de Janeiro, Brasil
    Biologicals 37:173-6. 2009
  3. ncbi request reprint [Vaccines, immunization and technological innovation: an update]
    Akira Homma
    Instituto de Tecnologia em Imunobiológicos de Bio Manguinhos, Rio de Janeiro RJ
    Cien Saude Colet 16:445-58. 2011
  4. ncbi request reprint Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type b
    Reinaldo de Menezes Martins
    Assessoria Clínica, Rio de Janeiro, RJ, Brasil
    Mem Inst Oswaldo Cruz 103:711-8. 2008
  5. ncbi request reprint Study of the genetic stability of measles virus CAM-70 vaccine strain after serial passages in chicken embryo fibroblasts primary cultures
    Maria Beatriz Borges
    Bio Manguinhos, Fundacao Oswaldo Cruz, Av Brasil, 4365 Manguinhos, Rio de Janeiro, RJ 21040 360, Brazil
    Virus Genes 36:35-44. 2008
  6. ncbi request reprint Incidence of hypotonic-hyporesponsive episodes associated to the combined DTP/Hib vaccine used in Brazilian National Immunizations Program
    Reinaldo M Martins
    Fundação Oswaldo Cruz FIOCRUZ, Rio de Janeiro, RJ, Brazil
    J Pediatr (Rio J) 83:523-8. 2007
  7. doi request reprint 17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study
    Reinaldo M Martins
    Bio Manguinhos, Fiocruz Rio de Janeiro, Brazil
    Hum Vaccin Immunother 9:879-88. 2013

Collaborators

  • Luiz Antonio Bastos Camacho
  • Rugimar Marcovistz
  • Reinaldo M Martins
  • Marcos S Freire
  • Ricardo Galler
  • Maria Beatriz Borges
  • Reinaldo de Menezes Martins
  • Ricardo de Carvalho
  • Sheila Maria B Lima
  • Edson Pereira Filho
  • Darcy A Hokama
  • Gloria Regina S Sá
  • Ricardo Aguiar V Freire
  • Luiz Fernando C Almeida
  • Maria da Luz Fernandes Leal
  • Anna Maya Yoshida Yamamura
  • Rita Maria R Nogueira
  • Maria de Lourdes S Maia
  • Roberto Henrique G Farias
  • Patricia Cristina Neves Feliciano de Souza
  • Glayse Glayde Barbosa
  • Elena Caride
  • Andrea Marques Vieira da Silva
  • José Marcus N Malachias
  • Tatiana Guimarães de Noronha
  • Eliane Matos dos Santos
  • Maria de Lourdes Sousa Maia
  • Alfredo V Jabor
  • Maria Cristina Ferreira Lemos
  • Maria Lourdes S Maia
  • Marli M da Silva
  • Andre R Perisse
  • Maria Helena C de Carvalho
  • Tatiana G de Noronha
  • Maria Cristina F Lemos
  • Nadja Greffe

Detail Information

Publications7

  1. ncbi request reprint Vaccine research, development, and innovation in Brazil: a translational science perspective
    Akira Homma
    Bio Manguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
    Vaccine 31:B54-60. 2013
    ..We also discuss the lessons learned from the Brazilian experience in the implementation of governmental policies on vaccine innovation that could be applicable to other developing countries...
  2. doi request reprint The Brazilian vaccine manufacturers' perspective and its current status
    Akira Homma
    Bio Manguinhos Fiocruz, Pavilhão Rocha Lima, Manguinhos, Rio de Janeiro, Brasil
    Biologicals 37:173-6. 2009
    ....
  3. ncbi request reprint [Vaccines, immunization and technological innovation: an update]
    Akira Homma
    Instituto de Tecnologia em Imunobiológicos de Bio Manguinhos, Rio de Janeiro RJ
    Cien Saude Colet 16:445-58. 2011
    ..Brazil has also established a new innovation policy, creating new laws as well as subsidizing projects in technological innovation and modernization of production infra-structure...
  4. ncbi request reprint Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type b
    Reinaldo de Menezes Martins
    Assessoria Clínica, Rio de Janeiro, RJ, Brasil
    Mem Inst Oswaldo Cruz 103:711-8. 2008
    ..Adverse events rates were comparable among the vaccine groups. The Brazilian DTP/Hib vaccine demonstrated an immunogenicity and reactogenicity profile similar to that of the reference vaccine...
  5. ncbi request reprint Study of the genetic stability of measles virus CAM-70 vaccine strain after serial passages in chicken embryo fibroblasts primary cultures
    Maria Beatriz Borges
    Bio Manguinhos, Fundacao Oswaldo Cruz, Av Brasil, 4365 Manguinhos, Rio de Janeiro, RJ 21040 360, Brazil
    Virus Genes 36:35-44. 2008
    ..This study shows that the measles CAM-70 vaccine virus is highly adapted to its cultivation conditions and that its genetic stability contributes, in part, to the safety profile of the vaccine...
  6. ncbi request reprint Incidence of hypotonic-hyporesponsive episodes associated to the combined DTP/Hib vaccine used in Brazilian National Immunizations Program
    Reinaldo M Martins
    Fundação Oswaldo Cruz FIOCRUZ, Rio de Janeiro, RJ, Brazil
    J Pediatr (Rio J) 83:523-8. 2007
    ..To evaluate the safety of a combined diphtheria-tetanus-whole cell pertussis-Haemophilus influenzae type b vaccine used on the Brazilian National Immunizations Program, chiefly the incidence of hypotonic-hyporesponsive episodes...
  7. doi request reprint 17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study
    Reinaldo M Martins
    Bio Manguinhos, Fiocruz Rio de Janeiro, Brazil
    Hum Vaccin Immunother 9:879-88. 2013
    ..To verify if the Bio-Manguinhos 17DD yellow fever vaccine (17DD-YFV) used in lower doses is as immunogenic and safe as the current formulation...